157 related articles for article (PubMed ID: 29314418)
21. Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRI.
Wongsawaeng D; Schwartz D; Li X; Muldoon LL; Stoller J; Stateler C; Holland S; Szidonya L; Rooney WD; Wyatt C; Ambady P; Fu R; Neuwelt EA; Barajas RF
Neuroradiol J; 2024 Mar; ():19714009241242596. PubMed ID: 38544404
[TBL] [Abstract][Full Text] [Related]
22. Analysis of postprocessing steps for residue function dependent dynamic susceptibility contrast (DSC)-MRI biomarkers and their clinical impact on glioma grading for both 1.5 and 3T.
Bell LC; Stokes AM; Quarles CC
J Magn Reson Imaging; 2020 Feb; 51(2):547-553. PubMed ID: 31206948
[TBL] [Abstract][Full Text] [Related]
23. Cerebral blood volume estimation by ferumoxytol-enhanced steady-state MRI at 9.4 T reveals microvascular impact of α1 -adrenergic receptor antibodies.
Pohlmann A; Karczewski P; Ku MC; Dieringer B; Waiczies H; Wisbrun N; Kox S; Palatnik I; Reimann HM; Eichhorn C; Waiczies S; Hempel P; Lemke B; Niendorf T; Bimmler M
NMR Biomed; 2014 Sep; 27(9):1085-93. PubMed ID: 25060359
[TBL] [Abstract][Full Text] [Related]
24. Voxel-based evidence of perfusion normalization in glioblastoma patients included in a phase I-II trial of radiotherapy/tipifarnib combination.
Ken S; Deviers A; Filleron T; Catalaa I; Lotterie JA; Khalifa J; Lubrano V; Berry I; Péran P; Celsis P; Moyal EC; Laprie A
J Neurooncol; 2015 Sep; 124(3):465-73. PubMed ID: 26189058
[TBL] [Abstract][Full Text] [Related]
25. Brain Iron Assessment after Ferumoxytol-enhanced MRI in Children and Young Adults with Arteriovenous Malformations: A Case-Control Study.
Iv M; Ng NN; Nair S; Zhang Y; Lavezo J; Cheshier SH; Holdsworth SJ; Moseley ME; Rosenberg J; Grant GA; Yeom KW
Radiology; 2020 Nov; 297(2):438-446. PubMed ID: 32930651
[TBL] [Abstract][Full Text] [Related]
26. Crossover comparison of ferumoxytol and gadobenate dimeglumine for abdominal MR-angiography at 3.0 tesla: Effects of contrast bolus length and flip angle.
Schubert T; Motosugi U; Kinner S; Colgan TJ; Sharma SD; Hetzel S; Wells S; Campo CA; Reeder SB
J Magn Reson Imaging; 2017 Jun; 45(6):1617-1626. PubMed ID: 27862577
[TBL] [Abstract][Full Text] [Related]
27. Cerebral blood perfusion deficits using dynamic susceptibility contrast MRI with gadolinium chelates in rats with post-ischemic reperfusion without significant dynamic contrast-enhanced MRI-derived vessel permeabilities: A cautionary note.
Jin S; Kang M; Cho H
PLoS One; 2018; 13(7):e0201076. PubMed ID: 30044884
[TBL] [Abstract][Full Text] [Related]
28. High-resolution cerebral blood volume imaging in humans using the blood pool contrast agent ferumoxytol.
Christen T; Ni W; Qiu D; Schmiedeskamp H; Bammer R; Moseley M; Zaharchuk G
Magn Reson Med; 2013 Sep; 70(3):705-10. PubMed ID: 23001902
[TBL] [Abstract][Full Text] [Related]
29. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
30. Tumor recurrence versus treatment effects in glioma: A comparative study of three dimensional pseudo-continuous arterial spin labeling and dynamic susceptibility contrast imaging.
Xu Q; Liu Q; Ge H; Ge X; Wu J; Qu J; Xu K
Medicine (Baltimore); 2017 Dec; 96(50):e9332. PubMed ID: 29390403
[TBL] [Abstract][Full Text] [Related]
31. Prospective Imaging Trial Assessing Gadoteridol Retention in the Deep Brain Nuclei of Women Undergoing Breast MRI.
Neal CH; Pujara AC; Srinivasan A; Chenevert TL; Malyarenko D; Khalatbari S; Helvie MA; Noroozian M; Jeruss JS; Pearlman MD; Davenport MS
Acad Radiol; 2020 Dec; 27(12):1734-1741. PubMed ID: 32107123
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of a high relaxivity contrast agent administered at half dose in dynamic susceptibility contrast MRI of brain gliomas.
Crisi G; Filice S; Erb G; Bozzetti F
J Magn Reson Imaging; 2017 Feb; 45(2):500-506. PubMed ID: 27373976
[TBL] [Abstract][Full Text] [Related]
33. Perfusion Maps Acquired From Dynamic Angiography MRI Using Deep Learning Approaches.
Asaduddin M; Roh HG; Kim HJ; Kim EY; Park SH
J Magn Reson Imaging; 2023 Feb; 57(2):456-469. PubMed ID: 35726646
[TBL] [Abstract][Full Text] [Related]
34. Contrast-enhanced functional blood volume imaging (CE-fBVI): enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol.
Qiu D; Zaharchuk G; Christen T; Ni WW; Moseley ME
Neuroimage; 2012 Sep; 62(3):1726-31. PubMed ID: 22584230
[TBL] [Abstract][Full Text] [Related]
35. Susceptibility weighted imaging and quantitative susceptibility mapping of the cerebral vasculature using ferumoxytol.
Liu S; Brisset JC; Hu J; Haacke EM; Ge Y
J Magn Reson Imaging; 2018 Mar; 47(3):621-633. PubMed ID: 28731570
[TBL] [Abstract][Full Text] [Related]
36. Comparing the signal enhancement of a gadolinium based and an iron-oxide based contrast agent in low-field MRI.
van Zandwijk JK; Simonis FFJ; Heslinga FG; Hofmeijer EIS; Geelkerken RH; Ten Haken B
PLoS One; 2021; 16(8):e0256252. PubMed ID: 34403442
[TBL] [Abstract][Full Text] [Related]
37. Safety and technique of ferumoxytol administration for MRI.
Vasanawala SS; Nguyen KL; Hope MD; Bridges MD; Hope TA; Reeder SB; Bashir MR
Magn Reson Med; 2016 May; 75(5):2107-11. PubMed ID: 26890830
[TBL] [Abstract][Full Text] [Related]
38. Use of dynamic susceptibility-contrast MRI (DSC-MRI) to assess perfusion changes in the ipsilateral brain parenchyma from glioblastoma.
Ulmer S; Liess C; Kesari S; Otto N; Straube T; Jansen O
J Neurooncol; 2009 Jan; 91(2):213-20. PubMed ID: 18807224
[TBL] [Abstract][Full Text] [Related]
39. The potential of ferumoxytol nanoparticle magnetic resonance imaging, perfusion, and angiography in central nervous system malignancy: a pilot study.
Neuwelt EA; Várallyay CG; Manninger S; Solymosi D; Haluska M; Hunt MA; Nesbit G; Stevens A; Jerosch-Herold M; Jacobs PM; Hoffman JM
Neurosurgery; 2007 Apr; 60(4):601-11; discussion 611-2. PubMed ID: 17415196
[TBL] [Abstract][Full Text] [Related]
40. 4D flow image quality with blood pool contrast: a comparison of gadofosveset trisodium and ferumoxytol.
Mukai K; Burris NS; Mahadevan VS; Foster ED; Ordovas KG; Hope MD
Int J Cardiovasc Imaging; 2018 Feb; 34(2):273-279. PubMed ID: 28884401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
